Page 254 - Read Online
P. 254

Seko. Vessel Plus 2020;4:22  I  http://dx.doi.org/10.20517/2574-1209.2020.14                                                           Page 7 of 7

               Ethical approval and consent to participate
               Not applicable.


               Consent for publication
               Not applicable.


               Copyright
               © The Author(s) 2020.


               REFERENCES
               1.   Chien CT, Lee PH, Chen CF, Ma MC, Lai MK, et al. De novo demonstration and co-localization of free-radical production and apoptosis
                   formation in rat kidney subjected to ischemia/reperfusion. J Am Soc Nephrol 2001;12:973-82.
               2.   Kaminski KA, Bonda TA, Korecki J, Musial WJ. Oxidative stress and neutrophil activation - the two keystones of ischemia/reperfusion
                   injury. Int J Cardiol 2002;86:41-59.
               3.   Madamanchi NR, Vendrov A, Runge MS. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 2005;25:29-38.
               4.   Vogiatzi G, Tousoulis D, Stefanadis C. The role of oxidative stress in atherosclerosis. Hellenic J Cardiol 2009;50:402-9.
               5.   Myung SK, Ju W, Cho B, Oh SW, Park SM, et al. Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular
                   disease: systematic review and meta-analysis of randomised controlled trials. Br Med J 2013;346:f10.
               6.   Seko Y, Fujimura T, Yao T, Taka H, Mineki R, et al. Secreted tyrosine sulfated-eIF5A mediates oxidative stress-induced apoptosis. Sci
                   Rep 2015;5:13737.
               7.   Caraglia M, Marra M, Giuberti G, D’Alessandro AM, Budillon A, et al. The role of eukaryotic initiation factor 5A in the control of cell
                   proliferation and apoptosis. Amino Acids 2001;20:91-104.
               8.   Yao T, Fujimura T, Murayama K, Seko Y. Plasma levels of oxidative stress-responsive apoptosis inducing protein (oraip) in rats subjected
                   to physicochemical oxidative stresses. Bioscience Rep 2016;36: e00317.
               9.   Tanaka K, Yao T, Fujimura T, Murayama K, Fukuda S, et al. Marked elevation of plasma levels of oxidative stress-responsive apoptosis
                   inducing protein in dialysis patients. Kidney Int Rep 2016;1:321-4.
               10.  Yao T, Tanaka K, Fujimura T, Murayama K, Fukuda S, et al. Plasma levels of oxidative stress-responsive apoptosis inducing protein
                   (ORAIP) in patients with atrial fibrillation. Int J Cardiol 2016;222:528-30.
               11.  Tanaka K, Yao T, Sato K, Okumura K, Seko Y. Oxidative stress-responsive apoptosis inducing protein (ORAIP) plays a critical role in the
                   cardiac injury in patients with heart failure. Ann Pharmacol Pharm 2017;2:1100.
               12.  Suzuki Y, Yao T, Okumura K, Seko Y, Kitano S. Elevation of vitreous body concentrations of oxidative stress-responsive apoptosis
                   inducing protein (ORAIP) in diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 2019;257:1519-25.
               13.  Schmid-Schonbein GW. Capillary plugging by granulocytes and the no-reflow phenomenon in the microcirculation. FASEB J
                   1987;46:2397-401.
               14.  Mehta JL, Nichols WW, Mehta P. Neutrophils as potential participants in acute myocardial ischemia: relevance to reperfusion. J Am Coll
                   Cardiol 1988;11:1309-16.
               15.  Simpson PJ, Lucchesi BR. Free radicals and myocardial ischemia and reperfusion injury. J Lab Clin Med 1987;110:13-30.
               16.  Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler RL. Reperfision injury induces apoptosis in rabbit cardiomyocytes. J Clin
                   Invest 1994;94:1621-8.
               17.  Bielawska AE, Shapiro JP, Jiang L, Melkonyan HS, Piot C, et al. Ceramide is involved in triggering of cardiomyocytes apoptosis induced
                   by ischemia and reperfusion. Am J Pathol 1997;151:1257-63.
               18.  Kishimoto M, Suenaga J, Takase H, Araki K, Yao T, et al. Oxidative stress-responsive apoptosis inducing protein (ORAIP) plays a critical
                   role in cerebral ischemia/reperfusion injury. Sci Rep 2019;9:13512.
               19.  Bonomini F, Tengattini S, Fabiano A, Bianchi R, Rezzani R. Atherosclerosis and oxidative stress. Histol Histopathol 2008;23:381-90.
               20.  Morel DW, Hessler JR, Chisolm GM. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. J Lipid Res
                   1983;24:1070-6.
               21.  Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D. Modification of low density lipoprotein by endothelial cells
                   involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA 1984;81:3883-7.
               22.  Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that
                   increase its atherogenicity. N Engl J Med 1989;320:915-24.
               23.  Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-20.
               24.  Yao T, Fujimura T, Murayama K, Okumura K, Seko Y. Oxidative stress-responsive apoptosis inducing protein (ORAIP) plays a critical
                   role in high glucose-induced apoptosis in rat cardiac myocytes and murine pancreatic β-cells. Cells 2017;6:35.
               25.  Tomita T. Apoptosis in pancreatic β-islet cells in Type 2 diabetes. Bosn J Basic Med Sci 2016;16:162-79.
               26.  Brownlee M. The pathophysiology of diabetic complications. Diabetes 2005;54:1615-25.
               27.  Amato R, Biagioni M, Cammalleri M, Dal Monte M, Casini G. VEGF as a survival factor in ex vivo models of early diabetic retinopathy.
                   Invest Ophthalmol Vis Sci 2016;57:3066-76.
               28.  Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, et al. Oxidative stress in end-stage renal disease: an emerging threat to
                   patient outcome. Nephrol Dial Transplant 2003;18:1272-80.
   249   250   251   252   253   254   255   256   257   258   259